Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Status:
Unknown status
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase II trial is to determine the feasibility and efficacy of
nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable
locally advanced cervical cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Air Force Military Medical University, China Fourth Military Medical University